Fibrocytes in Health and Disease.

By: Bucala, RichardPublisher: Singapore : World Scientific Publishing Co Pte Ltd, 2011Copyright date: ©2012Description: 1 online resource (335 pages)Content type: text Media type: computer Carrier type: online resourceISBN: 9789814343725Subject(s): Fibroblasts.;Connective tissues -- DiseasesGenre/Form: Electronic books. Additional physical formats: Print version:: Fibrocytes in Health and DiseaseDDC classification: 611.0181 LOC classification: QP88.23 -- .B83 2012ebOnline resources: Click to View
Contents:
Intro -- Contents -- Preface -- Contributors -- Chapter 1. Hematopoietic Origin of Fibrocytes Mehrdad Abedi -- 1.1. Introduction -- 1.2. Structure of Bone Marrow -- 1.3. Marrow-Derived Fibroblasts -- 1.4. Origin of Fibroblasts in Tissue -- 1.5. Fibrocytes -- 1.6. What is the Relation between Macrophages and Circulating Fibroblasts Precursors? -- 1.7. Perspective -- References -- Chapter 2. Fibrocytes and Collagen-Producing Cells of the Peripheral Blood Richard H. Gomer and Darrell Pilling -- 2.1. Introduction: Fibrocytes Precursors Originate in Bone Marrow, and Exist in Blood -- 2.2. The Chemokine CXCL12 Attracts Circulating Fibrocyte Precursors to Sites of Injury -- 2.3. Identification of Circulating CCPCs in the Blood -- 2.4. Pulmonary Fibrosis Patients have Abnormally High Numbers of CCPCs -- 2.5. Scleroderma Patients have Abnormally High Numbers of CCPCs -- 2.6. Differences between CCPCs from Scleroderma Patients and Controls -- 2.7. Patients with Chronic Asthma have Abnormally High Numbers of CCPCs -- 2.8. CCPCs in Rheumatoid Arthritis Patients -- 2.9. The Number of CCPCs Increases with Age -- 2.10. The Number of CCPCs Increases in an Animal Injury Model -- 2.11. Summary and Future Directions -- Acknowledgements -- References -- Chapter 3. Regulatory Pathways of Fibrocyte Development Darrell Pilling and Richard H. Gomer -- 3.1. Introduction -- 3.2. Inhibition of Initial Fibrocyte Differentiation by Fcγ Receptor Ligation -- 3.3. Inhibition of Initial Fibrocyte Differentiation by Cytokines -- 3.4. Profibrotic Cytokines Promote Fibrocyte Differentiation -- 3.5. Regulation of Mature Fibrocyte Differentiation -- References -- Chapter 4. Fibrocyte Differentiation Pathways Ellen C. Keeley, Borna Mehrad and Robert M. Strieter -- 4.1. Introduction -- 4.2. Fibrocyte Differentiation along Mesenchymal Lineages -- 4.2.1. Myofibroblasts.
4.2.2. Adipocytes -- 4.2.3. Osteoblasts and Chondrocytes -- 4.3. Fibrocytes can be Reprogrammed to Modify the Fibroproliferative Response -- 4.4. Factors that Influence Differentiation of Fibrocytes from their Precursors -- 4.5. Conclusion -- References -- Chapter 5. Immunoregulation of Fibrocyte Differentiation Matthias Mack, Marianne Niedermeier and Barbara Reich -- 5.1. Detection and Origin of Fibrocytes -- 5.2. Interaction of Monocytes with CD4+ T Cells Enables Differentiation of Fibrocytes -- 5.3. Cytokines and CD4+ T Cell Phenotypes Regulate Fibrocyte Differentiation -- 5.4. Influence of Serum on Fibrocyte Differentiation -- 5.5. Proliferation of Fibrocytes? -- 5.6. Migration of Fibrocytes -- 5.7. How Fibrocytes Affect CD4+ T Cells -- 5.8. Conclusion -- References -- Chapter 6. The Role of Fibrocytes in Wound Repair and Hypertrophic Scarring Abelardo Medina, Jie Ding, Moein Momtazi, and Edward E. Tredget -- 6.1. Introduction -- 6.2. Dysregulated Repair of the Extracellular Matrix of Hypertrophic Scars -- 6.3. Dysregulated Apoptosis in Hypertrophic Scar -- 6.4. Increased Levels of the Profibrotic Growth Factors TGF-β and CTGF in Hypertrophic Scarring -- 6.5. Circulating Bone Marrow-Derived Fibrocytes in Hypertrophic Scarring -- 6.6. Characterization of Human Fibrocytes -- 6.7. Increased Numbers of Fibrocytes Found in the Blood and Hypertrophic Scar of Burn Patients -- 6.8. Angiogenic Effects of Fibrocytes in Wound Healing -- 6.9. Effects of Cell-To-Cell Interaction between Fibrocytes and Fibroblasts -- 6.10. Fibrocytes May Contribute to the Myofibroblast Population -- 6.11. Fibrocyte Reprogramming and Tissue Remodeling Capacity of Fibroblasts -- 6.12. Possible Role of Fibrocytes in Hypertrophic Scarring Via Polarized Th2 Immune Response -- 6.13. Proposed Role of Fibrocytes in a Model of Fibroproliferative Switch in Wound Healing.
6.14. Summary and Prospects for Future Work -- Acknowledgments -- References -- Chapter 7. Fibrocytes in Asthma Sabrina Mattoli, Marek Barczyk and Alberto Bellini -- 7.1. Introduction -- 7.2. Inflammation and Airway Remodeling in Asthma -- 7.3. Fibrocyte Involvement in Allergen-Exacerbated Asthma -- 7.4. Fibrocyte Trafficking and Localization in Relation to Asthma Severity -- 7.5. Fibrocyte Function in Asthma -- 7.6. Conclusions -- Acknowledgments -- References -- Chapter 8. Fibrocytes in Interstitial Lung Disease Borna Mehrad, Ellen C. Keeley, Martin Kolb and Robert M. Strieter -- 8.1. Introduction -- 8.2. Data from Animal Models of Lung Fibrosis -- 8.2.1. Association of Fibrocytes with Lung Fibrosis -- 8.2.2. Mechanisms of Fibrocyte Migration to the Lungs -- 8.2.3. Fibrocyte Differentiation and Proliferation -- 8.3. Data from Human Studies -- 8.4. Conclusion -- References -- Chapter 9. Fibrocytes in Lung Fibrosis: Insights from Animal Models and Clinical Studies Payal Naik and Bethany B. Moore -- 9.1. Introduction -- 9.2. Idiopathic Pulmonary Fibrosis Clinical Problem and Significance -- 9.3. Natural History and Exacerbations of IPF -- 9.4. Animal Models of Fibrosis -- 9.5. Origin of Interstitial Fibroblasts -- 9.6. Fibrocyte Identification and Characterization -- 9.7. Migration of Mesenchymal Cell Precursors -- 9.8. Animal Models have Informed Our Understanding of Fibrocyte Migration -- 9.9. CCR2 in IPF and Animal Models of Fibrosis -- 9.10. Chimera Studies Indicate that Fibrocytes are Bone Marrow-Derived and Accumulation of Fibrocytes Correlate with the Degree of Lung Fibrosis -- 9.11. Differential Regulation of Fibrocyte Functions by CCR2 Ligand -- 9.12. Eicosanoid Regulation of Fibrocyte Function -- 9.13. The Interaction between Herpesviruses and Fibrocytes in Animal Models of Lung Fibrosis.
9.14. Latent Gammaherpesvirus Infection Augments Experimental Fibrosis -- 9.15. Lytic Herpesvirus Exacerbates Established Pulmonary Fibrosis -- 9.16. Conclusions from Animal Models -- 9.17. Fibrocytes in Human Asthma -- 9.18. Fibrocytes in Systemic Sclerosis -- 9.19. Fibrocytes in IPF -- 9.20. Fibrocytes as Biomarkers -- References -- Chapter 10. Fibrocytes in Scleroderma-Related Interstitial Lung Disease Susan K. Mathai and Erica L. Herzog -- 10.1. Introduction -- 10.2. Presence of Fibrocytes in Scleroderma -- 10.3. Murine Models of Scleroderma Lung Disease -- 10.4. Relationship to Injury and Apoptosis -- 10.5. Relationship to Macrophages -- 10.6. Immunologic Milieu -- 10.7. Semaphorin 7a -- 10.8. Caveolin-1 -- 10.9. Conclusion and Opportunities for Further Study -- References -- Chapter 11. Fibrocytes in the Etiopathogenesis of Nephrogenic Systemic Fibrosis Richard Bucala -- 11.1. Introduction -- 11.2. Nephrogenic Systemic Fibrosis -- 11.3. Role of Fibrocytes in NSF -- 11.4. Conclusion -- References -- Chapter 12. Myeloid Fibroblast Precursors in Cardiac Interstitial Fibrosis - The Origin of Fibroblast Precursors Dictates the Pathophysiologic Role Mark L. Entman, Katarzyna A. Cieslik, Signe Carlson, Sandra B. Haudek, and JoAnn Trial -- 12.1. Introduction -- 12.1.1. Fibrous Deposition -- 12.1.2. Fibrous Tissue and Myocardial Repair -- 12.1.3. Fibrous Tissue as an Adverse Pathologic Factor -- 12.1.4. Fibroblast Precursors and Their Origin -- 12.1.5. The Cell Biological Approach to Fibrosis and Fibroblast Development - Fibroblast Precursors and Their Signaling -- 12.2. MCP-1 Dysregulation and Cardiac Interstitial Fibrosis -- 12.2.1. Monocyte Chemoattractant Protein-1 -- 12.2.1.1. Chemokine Suppression - Role of TGF-β and IL-10 -- 12.2.2. Noninfarctive Chemokine-Induced Cardiomyopathy - Phenotype and Role of MCP-1 Dysregulation.
12.2.2.1. Role of MCP-1 -- 12.2.2.2. MCP-1 Deletion -- 12.2.3. Fibroblasts and Marrow-Derived Blood-Borne Fibroblast Precursors -- 12.2.4. MCP-1 Dysregulation - A Primary Etiology of I/RC -- 12.3. Monocyte to Fibroblast Transition - An In Vitro Model for Parallel Examination of Cellular Mechanisms in I/RC -- 12.3.1. Monocyte to Fibroblast Transition Requires MCP-1-Induced Transendothelial Migration -- 12.3.2. SAP and the FcγR -- 12.3.3. Rho Kinase and Reactive Fibrosis -- 12.3.4. ROCK1-/- in I/RC -- 12.3.5. IL-13 and Monocyte to Fibroblast Differentiation -- 12.4. Applicability of MCP-1-Monocyte- Fibroblast Transition Mechanism to Other Models of Pathological Interstitial Fibrosis -- 12.4.1. Angiotensin II -- 12.4.2. Interstitial Fibrosis in the Aging Heart -- 12.4.2.1. Aging Mice Developed Increased Interstitial Fibrosis -- 12.4.2.2. MCP-1 and CD45+ Fibroblasts Progressively Increase in the Aging Mouse Heart -- 12.4.2.3. Contrast Between Acute and Chronic Models -- 12.4.2.4. Interleukin-13 and the Th2 Phenotype -- 12.4.3. Human Studies -- 12.5. The Origin of Fibroblast Precursors Dictates the Pathophysiologic Role - An Hypothesis -- 12.5.1. Cardiac Interstitial Fibrosis and Adverse Remodeling -- 12.5.2. Fibroblast Precursors and Cardiac Scar Formation -- 12.5.3. Fibroblast Precursors May Have Dedicated Roles - An Hypothesis -- Acknowledgments -- References -- Chapter 13. Fibrocytes in Renal Fibrosis Norihiko Sakai, Kengo Furuichi, Kouji Matsushima, Shuichi Kaneko, and Takashi Wada -- 13.1. Introduction -- 13.2. Fibrocytes in an Experimental Renal Fibrosis Model -- 13.2.1. Detection of Fibrocytes in Fibrotic Kidneys -- 13.2.2. CCL21/CCR7 Signaling Regulates Fibrocytes Infiltration and Renal Fibrosis -- 13.2.3. Infiltration Routes of Fibrocytes to Fibrotic Kidneys.
13.2.4. Effect of Blockade of CCL21/CCR7 Signaling on Expression of Renal Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) and Infiltration of F4/80-Positive Macrophages.
Summary: Key Features:Unique volume on the topic of fibrocytesSupercedes a WSPC book published in 2007Contributed by international leaders in fibrocyte research.
Holdings
Item type Current library Call number Status Date due Barcode Item holds
Ebrary Ebrary Afghanistan
Available EBKAF00064226
Ebrary Ebrary Algeria
Available
Ebrary Ebrary Cyprus
Available
Ebrary Ebrary Egypt
Available
Ebrary Ebrary Libya
Available
Ebrary Ebrary Morocco
Available
Ebrary Ebrary Nepal
Available EBKNP00064226
Ebrary Ebrary Sudan

Access a wide range of magazines and books using Pressreader and Ebook central.

Enjoy your reading, British Council Sudan.

Available
Ebrary Ebrary Tunisia
Available
Total holds: 0

Intro -- Contents -- Preface -- Contributors -- Chapter 1. Hematopoietic Origin of Fibrocytes Mehrdad Abedi -- 1.1. Introduction -- 1.2. Structure of Bone Marrow -- 1.3. Marrow-Derived Fibroblasts -- 1.4. Origin of Fibroblasts in Tissue -- 1.5. Fibrocytes -- 1.6. What is the Relation between Macrophages and Circulating Fibroblasts Precursors? -- 1.7. Perspective -- References -- Chapter 2. Fibrocytes and Collagen-Producing Cells of the Peripheral Blood Richard H. Gomer and Darrell Pilling -- 2.1. Introduction: Fibrocytes Precursors Originate in Bone Marrow, and Exist in Blood -- 2.2. The Chemokine CXCL12 Attracts Circulating Fibrocyte Precursors to Sites of Injury -- 2.3. Identification of Circulating CCPCs in the Blood -- 2.4. Pulmonary Fibrosis Patients have Abnormally High Numbers of CCPCs -- 2.5. Scleroderma Patients have Abnormally High Numbers of CCPCs -- 2.6. Differences between CCPCs from Scleroderma Patients and Controls -- 2.7. Patients with Chronic Asthma have Abnormally High Numbers of CCPCs -- 2.8. CCPCs in Rheumatoid Arthritis Patients -- 2.9. The Number of CCPCs Increases with Age -- 2.10. The Number of CCPCs Increases in an Animal Injury Model -- 2.11. Summary and Future Directions -- Acknowledgements -- References -- Chapter 3. Regulatory Pathways of Fibrocyte Development Darrell Pilling and Richard H. Gomer -- 3.1. Introduction -- 3.2. Inhibition of Initial Fibrocyte Differentiation by Fcγ Receptor Ligation -- 3.3. Inhibition of Initial Fibrocyte Differentiation by Cytokines -- 3.4. Profibrotic Cytokines Promote Fibrocyte Differentiation -- 3.5. Regulation of Mature Fibrocyte Differentiation -- References -- Chapter 4. Fibrocyte Differentiation Pathways Ellen C. Keeley, Borna Mehrad and Robert M. Strieter -- 4.1. Introduction -- 4.2. Fibrocyte Differentiation along Mesenchymal Lineages -- 4.2.1. Myofibroblasts.

4.2.2. Adipocytes -- 4.2.3. Osteoblasts and Chondrocytes -- 4.3. Fibrocytes can be Reprogrammed to Modify the Fibroproliferative Response -- 4.4. Factors that Influence Differentiation of Fibrocytes from their Precursors -- 4.5. Conclusion -- References -- Chapter 5. Immunoregulation of Fibrocyte Differentiation Matthias Mack, Marianne Niedermeier and Barbara Reich -- 5.1. Detection and Origin of Fibrocytes -- 5.2. Interaction of Monocytes with CD4+ T Cells Enables Differentiation of Fibrocytes -- 5.3. Cytokines and CD4+ T Cell Phenotypes Regulate Fibrocyte Differentiation -- 5.4. Influence of Serum on Fibrocyte Differentiation -- 5.5. Proliferation of Fibrocytes? -- 5.6. Migration of Fibrocytes -- 5.7. How Fibrocytes Affect CD4+ T Cells -- 5.8. Conclusion -- References -- Chapter 6. The Role of Fibrocytes in Wound Repair and Hypertrophic Scarring Abelardo Medina, Jie Ding, Moein Momtazi, and Edward E. Tredget -- 6.1. Introduction -- 6.2. Dysregulated Repair of the Extracellular Matrix of Hypertrophic Scars -- 6.3. Dysregulated Apoptosis in Hypertrophic Scar -- 6.4. Increased Levels of the Profibrotic Growth Factors TGF-β and CTGF in Hypertrophic Scarring -- 6.5. Circulating Bone Marrow-Derived Fibrocytes in Hypertrophic Scarring -- 6.6. Characterization of Human Fibrocytes -- 6.7. Increased Numbers of Fibrocytes Found in the Blood and Hypertrophic Scar of Burn Patients -- 6.8. Angiogenic Effects of Fibrocytes in Wound Healing -- 6.9. Effects of Cell-To-Cell Interaction between Fibrocytes and Fibroblasts -- 6.10. Fibrocytes May Contribute to the Myofibroblast Population -- 6.11. Fibrocyte Reprogramming and Tissue Remodeling Capacity of Fibroblasts -- 6.12. Possible Role of Fibrocytes in Hypertrophic Scarring Via Polarized Th2 Immune Response -- 6.13. Proposed Role of Fibrocytes in a Model of Fibroproliferative Switch in Wound Healing.

6.14. Summary and Prospects for Future Work -- Acknowledgments -- References -- Chapter 7. Fibrocytes in Asthma Sabrina Mattoli, Marek Barczyk and Alberto Bellini -- 7.1. Introduction -- 7.2. Inflammation and Airway Remodeling in Asthma -- 7.3. Fibrocyte Involvement in Allergen-Exacerbated Asthma -- 7.4. Fibrocyte Trafficking and Localization in Relation to Asthma Severity -- 7.5. Fibrocyte Function in Asthma -- 7.6. Conclusions -- Acknowledgments -- References -- Chapter 8. Fibrocytes in Interstitial Lung Disease Borna Mehrad, Ellen C. Keeley, Martin Kolb and Robert M. Strieter -- 8.1. Introduction -- 8.2. Data from Animal Models of Lung Fibrosis -- 8.2.1. Association of Fibrocytes with Lung Fibrosis -- 8.2.2. Mechanisms of Fibrocyte Migration to the Lungs -- 8.2.3. Fibrocyte Differentiation and Proliferation -- 8.3. Data from Human Studies -- 8.4. Conclusion -- References -- Chapter 9. Fibrocytes in Lung Fibrosis: Insights from Animal Models and Clinical Studies Payal Naik and Bethany B. Moore -- 9.1. Introduction -- 9.2. Idiopathic Pulmonary Fibrosis Clinical Problem and Significance -- 9.3. Natural History and Exacerbations of IPF -- 9.4. Animal Models of Fibrosis -- 9.5. Origin of Interstitial Fibroblasts -- 9.6. Fibrocyte Identification and Characterization -- 9.7. Migration of Mesenchymal Cell Precursors -- 9.8. Animal Models have Informed Our Understanding of Fibrocyte Migration -- 9.9. CCR2 in IPF and Animal Models of Fibrosis -- 9.10. Chimera Studies Indicate that Fibrocytes are Bone Marrow-Derived and Accumulation of Fibrocytes Correlate with the Degree of Lung Fibrosis -- 9.11. Differential Regulation of Fibrocyte Functions by CCR2 Ligand -- 9.12. Eicosanoid Regulation of Fibrocyte Function -- 9.13. The Interaction between Herpesviruses and Fibrocytes in Animal Models of Lung Fibrosis.

9.14. Latent Gammaherpesvirus Infection Augments Experimental Fibrosis -- 9.15. Lytic Herpesvirus Exacerbates Established Pulmonary Fibrosis -- 9.16. Conclusions from Animal Models -- 9.17. Fibrocytes in Human Asthma -- 9.18. Fibrocytes in Systemic Sclerosis -- 9.19. Fibrocytes in IPF -- 9.20. Fibrocytes as Biomarkers -- References -- Chapter 10. Fibrocytes in Scleroderma-Related Interstitial Lung Disease Susan K. Mathai and Erica L. Herzog -- 10.1. Introduction -- 10.2. Presence of Fibrocytes in Scleroderma -- 10.3. Murine Models of Scleroderma Lung Disease -- 10.4. Relationship to Injury and Apoptosis -- 10.5. Relationship to Macrophages -- 10.6. Immunologic Milieu -- 10.7. Semaphorin 7a -- 10.8. Caveolin-1 -- 10.9. Conclusion and Opportunities for Further Study -- References -- Chapter 11. Fibrocytes in the Etiopathogenesis of Nephrogenic Systemic Fibrosis Richard Bucala -- 11.1. Introduction -- 11.2. Nephrogenic Systemic Fibrosis -- 11.3. Role of Fibrocytes in NSF -- 11.4. Conclusion -- References -- Chapter 12. Myeloid Fibroblast Precursors in Cardiac Interstitial Fibrosis - The Origin of Fibroblast Precursors Dictates the Pathophysiologic Role Mark L. Entman, Katarzyna A. Cieslik, Signe Carlson, Sandra B. Haudek, and JoAnn Trial -- 12.1. Introduction -- 12.1.1. Fibrous Deposition -- 12.1.2. Fibrous Tissue and Myocardial Repair -- 12.1.3. Fibrous Tissue as an Adverse Pathologic Factor -- 12.1.4. Fibroblast Precursors and Their Origin -- 12.1.5. The Cell Biological Approach to Fibrosis and Fibroblast Development - Fibroblast Precursors and Their Signaling -- 12.2. MCP-1 Dysregulation and Cardiac Interstitial Fibrosis -- 12.2.1. Monocyte Chemoattractant Protein-1 -- 12.2.1.1. Chemokine Suppression - Role of TGF-β and IL-10 -- 12.2.2. Noninfarctive Chemokine-Induced Cardiomyopathy - Phenotype and Role of MCP-1 Dysregulation.

12.2.2.1. Role of MCP-1 -- 12.2.2.2. MCP-1 Deletion -- 12.2.3. Fibroblasts and Marrow-Derived Blood-Borne Fibroblast Precursors -- 12.2.4. MCP-1 Dysregulation - A Primary Etiology of I/RC -- 12.3. Monocyte to Fibroblast Transition - An In Vitro Model for Parallel Examination of Cellular Mechanisms in I/RC -- 12.3.1. Monocyte to Fibroblast Transition Requires MCP-1-Induced Transendothelial Migration -- 12.3.2. SAP and the FcγR -- 12.3.3. Rho Kinase and Reactive Fibrosis -- 12.3.4. ROCK1-/- in I/RC -- 12.3.5. IL-13 and Monocyte to Fibroblast Differentiation -- 12.4. Applicability of MCP-1-Monocyte- Fibroblast Transition Mechanism to Other Models of Pathological Interstitial Fibrosis -- 12.4.1. Angiotensin II -- 12.4.2. Interstitial Fibrosis in the Aging Heart -- 12.4.2.1. Aging Mice Developed Increased Interstitial Fibrosis -- 12.4.2.2. MCP-1 and CD45+ Fibroblasts Progressively Increase in the Aging Mouse Heart -- 12.4.2.3. Contrast Between Acute and Chronic Models -- 12.4.2.4. Interleukin-13 and the Th2 Phenotype -- 12.4.3. Human Studies -- 12.5. The Origin of Fibroblast Precursors Dictates the Pathophysiologic Role - An Hypothesis -- 12.5.1. Cardiac Interstitial Fibrosis and Adverse Remodeling -- 12.5.2. Fibroblast Precursors and Cardiac Scar Formation -- 12.5.3. Fibroblast Precursors May Have Dedicated Roles - An Hypothesis -- Acknowledgments -- References -- Chapter 13. Fibrocytes in Renal Fibrosis Norihiko Sakai, Kengo Furuichi, Kouji Matsushima, Shuichi Kaneko, and Takashi Wada -- 13.1. Introduction -- 13.2. Fibrocytes in an Experimental Renal Fibrosis Model -- 13.2.1. Detection of Fibrocytes in Fibrotic Kidneys -- 13.2.2. CCL21/CCR7 Signaling Regulates Fibrocytes Infiltration and Renal Fibrosis -- 13.2.3. Infiltration Routes of Fibrocytes to Fibrotic Kidneys.

13.2.4. Effect of Blockade of CCL21/CCR7 Signaling on Expression of Renal Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) and Infiltration of F4/80-Positive Macrophages.

Key Features:Unique volume on the topic of fibrocytesSupercedes a WSPC book published in 2007Contributed by international leaders in fibrocyte research.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2019. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.